A Study of Genital Cytology and Pathology in Patients with Confirmed HPV Associated Oropharyngeal Carcinoma

Overview

About this study

The purpose of this study is to determine the incidence of concomitant HPV associated genital lesions in female patients with confirmed HPV associated oropharyngeal cancers, to determine the risk of requiring additional procedures or treatments secondary to these diagnoses, and to determine the HPV subtypes and other risk factors associated with genital dysplasia among those with documented HPV status.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • All female patients seen in consultation at Mayo clinic Rochester through 2018 with the diagnosis of oropharyngeal carcinoma.

Exclusion Criteria:

  • Non-HPV associated tumors
  • Male patients.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Kathryn Van Abel, M.D.

Contact us for the latest status

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20463048

Mayo Clinic Footer